pharma · Spinal Cord Injury · Neurological; Disorder, Nervous System
UroGen Pharma
EuroGen Pharmaceuticals Ltd
EuroGen Pharmaceuticals is a pharma organization headquartered in GB. Primary therapeutic focus areas include Spinal Cord Injury, Neurological; Disorder, Nervous System. NovaPharmaNews links 2 clinical program(s), 0 drug
Princeton, USA HQ
2004 Founded
322 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Princeton, USA
- Founded
- 2004
- Employees
- 322
- Programs
- 2
- Drugs
- 5
- Patents
- 0
Autologous bone marrow mononuclear cell transplantation
Phase 2 · mab · Spinal Cord Injury
Autologous bone marrow mononuclear cell transplantation for Spinal Cord Injury is a Phase 2 program (mab) at EuroGen Pharmaceuticals Ltd with 1 ClinicalTrials.gov record(s).
Internal code NGBSI-03
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- EuroGen Pharmaceuticals Ltd
- Phase
- Phase 2
- Modality
- mab
- Indication
- Spinal Cord Injury
- Status
- terminated
- Trials
- 1